Navigation Links
Stanford scientists calculate the carbon footprint of grid-scale battery technologies
Date:3/8/2013

-acid technology is at the bottom, achieving a mere 700 cycles.

"The most effective way a storage technology can become less energy-intensive over time is to increase its cycle life," Benson said. "Most battery research today focuses on improving the storage or power capacity. These qualities are very important for electric vehicles and portable electronics, but not for storing energy on the grid. Based on our ESOI calculations, grid-scale battery research should focus on extending cycle life by a factor of 3 to 10."

In addition to energetic costs, Barnhart and Benson also calculated the material costs of building these grid-scale storage technologies.

"In general, we found that the material constraints aren't as limiting as the energetic constraints," Barnhart said. "It appears that there are plenty of materials in the Earth to build energy storage. There are exceptions, such as cobalt, which is used in some lithium-ion technologies, and vanadium, the key component of vanadium-redox flow batteries."

Pumped hydro storage faces another set of challenges. "Pumped hydro is energetically quite cheap, but the number of geologic locations conducive to pumped hydro is dwindling, and those that remain have environmental sensitivities," Barnhart said.

The study also assessed a promising technology called CAES, or compressed air energy storage. CAES works by pumping air at very high pressure into a massive cavern or aquifer, then releasing the compressed air through a turbine to generate electricity on demand. The Stanford team discovered that CAES has the fewest material constraints of all the technologies studied, as well as the highest ESOI value: 240. Two CAES facilities are operating today in Alabama and Germany.

Global warming impact

A primary goal of the study was to encourage the development of practical technologies that lower greenhouse emissions and curb global warming, Barnhart said. Coal- and n
'/>"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. Stanford scientists help shed light on key component of Chinas pollution problem
2. UC Berkeley, UCSF and Stanford join forces to help commercialize university innovations
3. Stanford researchers develop tool for reading the minds of mice
4. Going negative: Stanford scientists explore new technologies that remove atmospheric CO2
5. Stanford scientist uncovers the reproductive workings of a harvester ant dynasty
6. Stanford researcher sheds new light on the mysteries of spider silk
7. Stanford geoscientist cites critical need for basic research to unleash promising energy sources
8. Stanford scientists build the first all-carbon solar cell
9. Gladstone, Stanford scientists block toxic protein that plays key role in Lou Gehrigs disease
10. The 2013 HFSP Nakasone Award goes to Stephen Quake of Stanford University
11. Stanford bioengineer Christina Smolke wins NIH Directors Pioneer Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Stanford scientists calculate the carbon footprint of grid-scale battery technologies
(Date:7/8/2015)... LAKES , N.J. and NEW YORK ... Company) and Guidepoint today announced BD ... start-up healthcare companies with free access to Guidepoint,s expert ... several start-ups that are developing cutting-edge technologies to improve ... a dedicated Guidepoint research manager, each start-up entrepreneur will ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/2/2015)... , June 25, 2015 ... the addition of the "Natural Language Processing ... (Recognition, IVR, OCR, Pattern & Image Recognition) - ... offering. The key vendors occupying the ... IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... target blood vessels in fat and cause them to ... a model for future weight-loss therapies, say University of ... by Randy Seeley, PhD, of UC,s Metabolic Diseases Institute, ... peptide experienced decreased food intake and significant fat loss. ...
... Iowa February 1, 2010 Efforts will begin this ... by 21 percent and begin the development of a 30-mile ... group of 14 chimpanzees facing extinction. Organizers of the Gishwati ... fund reforestation of 647 acres (262 hectares) in the Kinyenkanda ...
... our brains are a lot more chaotic than previously ... Neurobiologists at the University of Maryland have discovered ... previous understandings of the auditory cortex, which had suggested ... first study of the auditory cortex conducted using advanced ...
Cached Biology News:'Starving' fat suppresses appetite 2Rwanda's Forest of Hope to expand by 21 percent, begin corridor for endangered chimpanzees 2Rwanda's Forest of Hope to expand by 21 percent, begin corridor for endangered chimpanzees 3Seeing the brain hear reveals surprises about how sound is processed 2Seeing the brain hear reveals surprises about how sound is processed 3
(Date:7/30/2015)... ... July 30, 2015 , ... ... a field clinical study of its canine osteoarthritis stem cell product, currently under ... (Kansas City, KS) and will be marketed in the US by Aratana. This ...
(Date:7/30/2015)... 30, 2015   Senomyx , Inc. (NASDAQ: ... technologies to discover, develop, and commercialize novel flavor ingredients ... reported financial results for the second quarter 2015. ... we remain on track to achieve our commercial and ... Officer of the Company. "Since our last quarterly earnings ...
(Date:7/30/2015)... , July 30, 2015 Ascendis Pharma ... that applies its innovative TransCon technology to address ... results from a six-month Phase 2 study to ... Growth Hormone in 53 treatment-naïve, pre-pubertal children with ... are extremely pleased with the top-line results from ...
(Date:7/30/2015)... 2015  Discovery Laboratories, Inc. (Nasdaq: DSCO ... second $1.0M tranche under a previously awarded Phase ... at up to $3.0 million to support continued ... a potential medical countermeasure to mitigate acute and ... an initial $1.0 million under this grant in ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... NEW YORK, June 3 American Oriental,Bioengineering (NYSE: ... to make a private,offer, subject to market conditions ... aggregate liquidation preference of newly,issued convertible preferred stock. ... dividends quarterly in arrears, and will be,convertible upon ...
... June 3, 2008, TIME: ... Dr. Candace Kendle, Chairman and CEO Kendle (Nasdaq: ... Tuesday, June 3 at 9:30 a.m. Eastern Time to,discuss the acquisition ... to provide an update on second quarter,progress. A question and answer ...
... and world-leading scientific psychopharmacology expertise; supports Kendle ... growth in its early phase business, ... KNDL ), a,leading global full-service clinical research ... Clinical Research Corporation,(DecisionLine Clinical Services), a privately ...
Cached Biology Technology:American Oriental Bioengineering Announces Proposed Private Offering to Raise $125 Million via Convertible Preferred Stock 2Kendle to Host Conference Call and Webcast to Discuss DecisionLine Acquisition and Provide Update on Second Quarter Progress 2Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 2Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 3Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 4Kendle Expands Global Clinical Pharmacology Capabilities with Acquisition of DecisionLine Clinical Research Corporation 5
... for automated bioresearch: Developed for a ... Based on decades of experience in ... for bioresearch • Holographic gratings for ... and ease-of-use • Pulsed Xenon lamp ...
... GenePix Pro is the industry standard microarray ... combination of imaging and analysis tools, visualizations, ... GenePix Pro is included with every GenePix ... from third-party scanners and all types of ...
... personal-sized Thermal Cycler is the ideal instrument for ... range of PCR applications. Get Applied ... Save lab space without sacrificing results. ... Industry-Standard PCR Technology You Can Afford ...
... Sigma-Genosys offers custom peptide synthesis with a ... to best fit your research needs. ... Yield: 2mg-1g Sequence Length: ... Biotin, Fluorescein, N-acetylation, C-amidation, phosphorylation, D-amino acids, ...
Biology Products: